AbbVie sharpens immunology focus with $10.9 billion Apogee deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. SPY
7. MMED
8. CRDO
9. AAPL
10. NVDA

Go back to AbbVie sharpens immunology focus with $10.9 billion Apogee deal
AbbVie (NYSE: ABBV) Delayed: 258.41 -1.58 (0.61%)
Previous Close $259.99    52 Week High $68.12 
Open $262.70    52 Week Low $50.71 
Day High $262.97    P/E 56.05 
Day Low $257.70    EPS $4.61 
Volume 1,476,020